StonvexLoading…
StonvexStonvexStonvexCore line items from STHO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $110.14M | $113.30M | $123.05M | $124.08M |
Operating Income | $-70.75M | $-88.36M | $-196.29M | $-36.31M |
Net Income | $-64.25M | $-86.75M | $-196.36M | $-36.35M |
EPS (Diluted) | $-4.90 | $-6.51 | $-14.74 | $-2.73 |
Total Assets | $570.20M | $608.65M | $669.20M | $1.01B |
Total Liabilities | $304.33M | $263.66M | $235.36M | $33.10M |
Cash & Equivalents | $50.08M | $34.96M | $50.66M | $4.23M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 12.32M | 13.32M | 13.32M | 0 |